---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-23-000034"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2023-02-28T23:59:59+00:00"
generated_at: "2026-06-18T22:15:33.745681+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst appoints Carle Health COO Matthew Kolb to board; Carle becomes shareholder

## Summary
- Matthew Kolb, EVP & COO of Carle Health, appointed to board effective July 1, 2023, filling a newly created seat.
- Carle Health purchased HCAT common stock on open market, becoming a meaningful shareholder.
- Carle expanded client relationship in Dec 2022 with a five-year contract for tech-enabled managed services and all-access subscription.
- Carle paid ~$5.5M in 2022; 2023 payments expected to slightly exceed 5% of HCAT's projected revenue.
- Kolb will not receive director compensation beyond expense reimbursement.

## SEC filing metadata
- accession: 0001636422-23-000034
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2023-02-28T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000034/0001636422-23-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000034/hcat-20230227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-23-000034
- JSON: https://secwatch.observer/filing/0001636422-23-000034.json
- Plain text: https://secwatch.observer/filing/0001636422-23-000034.txt

## Key facts
- Executive change
  Matthew Kolb was appointed as Director at Health Catalyst, Inc..
  - Action: appointed
  - Role: Director
  source text: On February 27, 2023, the board of directors (the “Board”) of Health Catalyst, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Matthew Kolb to the Board, effective July 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000034/0001636422-23-000034-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.